Michael A. Mussallem is CEO & Chairman at EDWARDS LIFESCIENCES CORP (EW). They have made 103 open-market trades across 1 company since 2006, most recently 2024-05-02.
CIK 0001204551
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 103 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL · 10b5-1 | 2024-05-02 | 2024-05-02 | $84.77 | $5.0M | +0.7% | +2.3% | -26.6% |
| EW | SELL · 10b5-1 | 2024-04-04 | 2024-04-04 | $92.41 | $5.4M | -1.5% | -6.9% | -0.4% |
| EW | SELL · 10b5-1 | 2024-03-04 | 2024-03-04 | $86.53 | $3.7M | +7.6% | +7.2% | +1.2% |
| EW | SELL · 10b5-1 | 2024-02-05 | 2024-02-05 | $87.45 | $5.0M | -0.1% | +2.6% | -1.2% |
| EW | SELL · 10b5-1 | 2024-01-05 | 2024-01-05 | $73.02 | $2.3M | +1.7% | +17.6% | +24.6% |
| EW | SELL · 10b5-1 | 2023-12-13 | 2023-12-13 | $74.71 | $3.6M | +0.3% | -2.7% | +19.5% |
| EW | SELL · 10b5-1 | 2023-11-03 | 2023-11-06 | $67.18 | $3.9M | -0.0% | +3.0% | +27.5% |
| EW | SELL · 10b5-1 | 2023-10-02 | 2023-10-02 | $68.84 | $2.0M | +1.9% | -7.0% | +10.1% |
| EW | SELL · 10b5-1 | 2023-09-05 | 2023-09-05 | $75.86 | $2.2M | -3.9% | -5.2% | -9.1% |
| EW | SELL · 10b5-1 | 2023-08-07 | 2023-08-07 | $79.87 | $2.3M | -2.7% | -2.6% | -15.1% |
| EW | SELL · 10b5-1 | 2023-07-05 | 2023-07-05 | $90.78 | $5.3M | +2.9% | -11.6% | -22.7% |
| EW | SELL · 10b5-1 | 2023-06-01 | 2023-06-01 | $84.46 | $5.0M | +2.1% | +6.9% | -9.1% |
| EW | SELL · 10b5-1 | 2023-05-10 | 2023-05-11 | $88.49 | $3.5M | -4.5% | -3.6% | -12.1% |
| EW | SELL · 10b5-1 | 2023-04-14 | 2023-04-17 | $84.20 | $3.3M | +2.5% | +3.7% | +9.6% |
| EW | SELL | 2023-03-14 | 2023-03-14 | $77.52 | $2.3M | +4.3% | +9.3% | +10.5% |
| EW | SELL | 2023-02-14 | 2023-02-14 | $76.92 | $2.8M | +1.7% | +7.8% | +17.0% |
| EW | SELL | 2023-01-13 | 2023-01-13 | $78.09 | $3.1M | +0.3% | -0.5% | +8.5% |
| EW | SELL | 2022-12-14 | 2022-12-14 | $76.39 | $3.0M | -1.6% | +4.7% | +4.5% |
| EW | SELL | 2022-11-14 | 2022-11-14 | $74.06 | $2.6M | +2.9% | +2.2% | +4.6% |
| EW | SELL | 2022-10-14 | 2022-10-14 | $82.72 | $3.1M | +3.5% | -12.3% | -7.2% |
| EW | SELL | 2022-09-22 | 2022-09-22 | $84.12 | $3.1M | +4.0% | +1.3% | -10.8% |
| EW | SELL | 2022-08-15 | 2022-08-15 | $104.74 | $4.2M | -7.1% | -9.6% | -29.4% |
| EW | SELL | 2022-07-14 | 2022-07-14 | $96.12 | $3.2M | +3.7% | +6.3% | -16.1% |
| EW | SELL | 2022-06-14 | 2022-06-14 | $86.96 | $3.5M | +10.2% | +10.4% | +10.9% |
| EW | SELL | 2022-05-10 | 2022-05-10 | $94.93 | $5.7M | -0.2% | -1.0% | +11.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.